Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 168

1.

Does adjuvant chemotherapy improve survival for women with early-stage uterine leiomyosarcoma?

Ricci S, Giuntoli RL 2nd, Eisenhauer E, Lopez MA, Krill L, Tanner EJ 3rd, Gehrig PA, Havrilesky LJ, Secord AA, Levinson K, Frasure H, Celano P, Fader AN.

Gynecol Oncol. 2013 Dec;131(3):629-33. doi: 10.1016/j.ygyno.2013.08.037. Epub 2013 Sep 7.

PMID:
24016408
2.

Adjuvant therapy for high-grade, uterus-limited leiomyosarcoma: results of a phase 2 trial (SARC 005).

Hensley ML, Wathen JK, Maki RG, Araujo DM, Sutton G, Priebat DA, George S, Soslow RA, Baker LH.

Cancer. 2013 Apr 15;119(8):1555-61. doi: 10.1002/cncr.27942. Epub 2013 Jan 18.

3.

Adjuvant gemcitabine plus docetaxel for completely resected stages I-IV high grade uterine leiomyosarcoma: Results of a prospective study.

Hensley ML, Ishill N, Soslow R, Larkin J, Abu-Rustum N, Sabbatini P, Konner J, Tew W, Spriggs D, Aghajanian CA.

Gynecol Oncol. 2009 Mar;112(3):563-7. doi: 10.1016/j.ygyno.2008.11.027. Epub 2009 Jan 9.

PMID:
19135708
4.

Platinum/taxane-based chemotherapy with or without radiation therapy favorably impacts survival outcomes in stage I uterine papillary serous carcinoma.

Fader AN, Drake RD, O'Malley DM, Gibbons HE, Huh WK, Havrilesky LJ, Gehrig PA, Tuller E, Axtell AE, Zanotti KM; Uterine Papillary Serous Carcinoma (UPSC) Consortium.

Cancer. 2009 May 15;115(10):2119-27. doi: 10.1002/cncr.24247.

5.

Adjuvant chemotherapy in stage I-II uterine leiomyosarcoma: a multicentric retrospective study of 140 patients.

Mancari R, Signorelli M, Gadducci A, Carinelli S, De Ponti E, Sesana S, Corso S, Chiappa V, Colombo N, Lissoni AA.

Gynecol Oncol. 2014 Jun;133(3):531-6. doi: 10.1016/j.ygyno.2014.03.001. Epub 2014 Mar 11.

PMID:
24631454
6.

Stage II uterine papillary serous carcinoma: Carboplatin/paclitaxel chemotherapy improves recurrence and survival outcomes.

Fader AN, Nagel C, Axtell AE, Zanotti KM, Kelley JL, Moore KN, Secord AA, Walsh CS, Huh WK, Gehrig PA, Gibbons H, Rose PG, Havrilesky LJ, Tuller E, Drake RD, Bottsford-Miller J, O'Malley DM; UPSC Consortium.

Gynecol Oncol. 2009 Mar;112(3):558-62. doi: 10.1016/j.ygyno.2008.11.016. Epub 2009 Jan 1.

PMID:
19118888
7.

Patterns of relapse in stage I-II uterine papillary serous carcinoma treated with adjuvant intravaginal radiation (IVRT) with or without chemotherapy.

Desai NB, Kiess AP, Kollmeier MA, Abu-Rustum NR, Makker V, Barakat RR, Alektiar KM.

Gynecol Oncol. 2013 Dec;131(3):604-8. doi: 10.1016/j.ygyno.2013.09.019. Epub 2013 Sep 20.

PMID:
24055615
8.

Pelvic radiation improves local control after hysterectomy for uterine leiomyosarcoma: a 20-year experience.

Mahdavi A, Monk BJ, Ragazzo J, Hunter MI, Lentz SE, Vasilev SA, Tewari KS.

Int J Gynecol Cancer. 2009 Aug;19(6):1080-4. doi: 10.1111/IGC.0b013e3181acae50.

PMID:
19820372
9.

Uterine leiomyosarcoma--a Singapore experience.

Soh LT, Chew SH, Ang L.

Aust N Z J Obstet Gynaecol. 1999 May;39(2):246-8.

PMID:
10755790
10.

Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome.

Callister M, Ramondetta LM, Jhingran A, Burke TW, Eifel PJ.

Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):786-96.

PMID:
14967435
11.

An updated clinicopathologic study of early-stage uterine papillary serous carcinoma (UPSC).

Fader AN, Starks D, Gehrig PA, Secord AA, Frasure HE, O'Malley DM, Tuller ER, Rose PG, Havrilesky LJ, Moore KN, Huh WK, Axtell AE, Kelley JL, Zanotti KM; UPSC Consortium.

Gynecol Oncol. 2009 Nov;115(2):244-8. doi: 10.1016/j.ygyno.2009.07.030. Epub 2009 Aug 26.

PMID:
19712966
12.

Prognostic factors and impact of adjuvant chemotherapy for uterine leiomyosarcoma.

Wu TI, Chang TC, Hsueh S, Hsu KH, Chou HH, Huang HJ, Lai CH.

Gynecol Oncol. 2006 Jan;100(1):166-72. Epub 2005 Sep 22.

PMID:
16182349
13.

Uterine leiomyosarcoma: analysis of treatment failures and survival.

Gadducci A, Landoni F, Sartori E, Zola P, Maggino T, Lissoni A, Bazzurini L, Arisio R, Romagnolo C, Cristofani R.

Gynecol Oncol. 1996 Jul;62(1):25-32.

PMID:
8690287
14.

A multi-institutional study of outcomes in stage I-III uterine carcinosarcoma.

Dickson EL, Vogel RI, Gehrig PA, Pierce S, Havrilesky L, Secord AA, Dottino J, Fader AN, Ricci S, Geller MA.

Gynecol Oncol. 2015 Nov;139(2):275-82. doi: 10.1016/j.ygyno.2015.09.002. Epub 2015 Sep 6.

PMID:
26348313
15.

A retrospective assessment of outcomes of chemotherapy-based versus radiation-only adjuvant treatment for completely resected stage I-IV uterine carcinosarcoma.

Makker V, Abu-Rustum NR, Alektiar KM, Aghajanian CA, Zhou Q, Iasonos A, Hensley ML.

Gynecol Oncol. 2008 Nov;111(2):249-54. doi: 10.1016/j.ygyno.2008.06.035. Epub 2008 Aug 27.

16.

Efficacy of adjuvant CYVADIC chemotherapy in early-stage uterine sarcomas: results of long-term follow-up.

Odunsi K, Moneke V, Tammela J, Ghamande S, Seago P, Driscoll D, Marchetti D, Baker T, Lele S.

Int J Gynecol Cancer. 2004 Jul-Aug;14(4):659-64.

PMID:
15304162
17.

A multi-institutional cohort study of adjuvant therapy in stage I-II uterine carcinosarcoma.

Cantrell LA, Havrilesky L, Moore DT, O'Malley D, Liotta M, Secord AA, Nagel CI, Cohn DE, Fader AN, Wallace AH, Rose P, Gehrig PA.

Gynecol Oncol. 2012 Oct;127(1):22-6. doi: 10.1016/j.ygyno.2012.06.020. Epub 2012 Jun 20.

PMID:
22727985
18.

Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy.

Giuntoli RL 2nd, Metzinger DS, DiMarco CS, Cha SS, Sloan JA, Keeney GL, Gostout BS.

Gynecol Oncol. 2003 Jun;89(3):460-9.

PMID:
12798712
19.

Role of adjuvant chemotherapy in patients with early stage uterine papillary serous cancer.

Mahdavi A, Tajalli TR, Dalmar A, Vasilev SA, Lentz SE, Berman ML.

Int J Gynecol Cancer. 2011 Nov;21(8):1436-40. doi: 10.1097/IGC.0b013e31822e7588.

PMID:
21997174
20.

On the apparent failure of adjuvant pelvic radiotherapy to improve survival for women with uterine sarcomas confined to the uterus.

Dusenbery KE, Potish RA, Argenta PA, Judson PL.

Am J Clin Oncol. 2005 Jun;28(3):295-300. Review.

PMID:
15923804
Items per page

Supplemental Content

Write to the Help Desk